Report Detail
Global (United States, European Union and China) HIV Drugs Market Research Report 2019-2025
- RnM3604017 |
- 19 July, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.
One of the primary factors catalyzing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments. Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.
In 2019, the market size of HIV Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for HIV Drugs.
This report studies the global market size of HIV Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the HIV Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
...
Market Segment by Product Type
Multi-Class Combination Products
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Entry Inhibitors - CCR5 Co-Receptor Antagonist
HIV Integrase Strand Transfer Inhibitors
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the HIV Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key HIV Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of HIV Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global HIV Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Multi-Class Combination Products
- 1.3.3 Nucleoside Reverse Transcriptase Inhibitors
- 1.3.4 Non-Nucleoside Reverse Transcriptase Inhibitors
- 1.3.5 Protease Inhibitors
- 1.3.6 Fusion Inhibitors
- 1.3.7 Entry Inhibitors - CCR5 Co-Receptor Antagonist
- 1.3.8 HIV Integrase Strand Transfer Inhibitors
- 1.4 Market Segment by Application
- 1.4.1 Global HIV Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global HIV Drugs Market Size
- 2.1.1 Global HIV Drugs Revenue 2014-2025
- 2.1.2 Global HIV Drugs Sales 2014-2025
- 2.2 HIV Drugs Growth Rate by Regions
- 2.2.1 Global HIV Drugs Sales by Regions 2014-2019
- 2.2.2 Global HIV Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 HIV Drugs Sales by Manufacturers
- 3.1.1 HIV Drugs Sales by Manufacturers 2014-2019
- 3.1.2 HIV Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 HIV Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 HIV Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global HIV Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 HIV Drugs Price by Manufacturers
- 3.4 Key Manufacturers HIV Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into HIV Drugs Market
- 3.6 Key Manufacturers HIV Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Multi-Class Combination Products Sales and Revenue (2014-2019)
- 4.1.2 Nucleoside Reverse Transcriptase Inhibitors Sales and Revenue (2014-2019)
- 4.1.3 Non-Nucleoside Reverse Transcriptase Inhibitors Sales and Revenue (2014-2019)
- 4.1.4 Protease Inhibitors Sales and Revenue (2014-2019)
- 4.1.5 Fusion Inhibitors Sales and Revenue (2014-2019)
- 4.1.6 Entry Inhibitors - CCR5 Co-Receptor Antagonist Sales and Revenue (2014-2019)
- 4.1.7 HIV Integrase Strand Transfer Inhibitors Sales and Revenue (2014-2019)
- 4.2 Global HIV Drugs Sales Market Share by Type
- 4.3 Global HIV Drugs Revenue Market Share by Type
- 4.4 HIV Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global HIV Drugs Sales by Application
6 United States
- 6.1 United States HIV Drugs Breakdown Data by Company
- 6.2 United States HIV Drugs Breakdown Data by Type
- 6.3 United States HIV Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union HIV Drugs Breakdown Data by Company
- 7.2 European Union HIV Drugs Breakdown Data by Type
- 7.3 European Union HIV Drugs Breakdown Data by Application
8 China
- 8.1 China HIV Drugs Breakdown Data by Company
- 8.2 China HIV Drugs Breakdown Data by Type
- 8.3 China HIV Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World HIV Drugs Breakdown Data by Company
- 9.2 Rest of World HIV Drugs Breakdown Data by Type
- 9.3 Rest of World HIV Drugs Breakdown Data by Application
- 9.4 Rest of World HIV Drugs Breakdown Data by Countries
- 9.4.1 Rest of World HIV Drugs Sales by Countries
- 9.4.2 Rest of World HIV Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bristol-Myers Squibb
- 10.1.1 Bristol-Myers Squibb Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of HIV Drugs
- 10.1.4 HIV Drugs Product Introduction
- 10.1.5 Bristol-Myers Squibb Recent Development
- 10.2 Gilead Sciences
- 10.2.1 Gilead Sciences Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of HIV Drugs
- 10.2.4 HIV Drugs Product Introduction
- 10.2.5 Gilead Sciences Recent Development
- 10.3 GlaxoSmithKline
- 10.3.1 GlaxoSmithKline Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of HIV Drugs
- 10.3.4 HIV Drugs Product Introduction
- 10.3.5 GlaxoSmithKline Recent Development
- 10.4 Johnson & Johnson
- 10.4.1 Johnson & Johnson Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of HIV Drugs
- 10.4.4 HIV Drugs Product Introduction
- 10.4.5 Johnson & Johnson Recent Development
- 10.5 Merck
- 10.5.1 Merck Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of HIV Drugs
- 10.5.4 HIV Drugs Product Introduction
- 10.5.5 Merck Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 HIV Drugs Sales Channels
- 11.2.2 HIV Drugs Distributors
- 11.3 HIV Drugs Customers
12 Market Forecast
- 12.1 Global HIV Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global HIV Drugs Sales Forecast by Type
- 12.3 Global HIV Drugs Sales Forecast by Application
- 12.4 HIV Drugs Forecast by Regions
- 12.4.1 Global HIV Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global HIV Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on HIV Drugs. Industry analysis & Market Report on HIV Drugs is a syndicated market report, published as Global (United States, European Union and China) HIV Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of HIV Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
